Pricing Log in Create free account

BioVie Inc. (BIVI) vs CytoMed Therapeutics Limited (GDTC)

BioVie Inc. and CytoMed Therapeutics Limited are both Biotechnology companies. BioVie Inc. and CytoMed Therapeutics Limited are of similar size ($10.3M and $9.6M). Across the 10 metrics below, CytoMed Therapeutics Limited leads on 6 and BioVie Inc. on 4.

Valuation

Metric BIVI GDTC Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.85 0.57 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (262.50%) (31.82%) (33.15%)
Free cash flow yield (218.80%) (0.38%) (25.50%)

Profitability

Metric BIVI GDTC Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (151.06%) 0.00% (56.36%)
Return on assets (123.51%) 0.00% (48.04%)
Return on invested capital (1,095.01%) 0.00% 0.00%

Growth

Metric BIVI GDTC Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 74.83% (68.75%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIVI GDTC Biotechnology median
Debt to equity 0.00 0.08 0.00
Current ratio 3.59 2.64 4.72
Net debt to EBITDA 0.40 0.86 0.96

Dividend

Metric BIVI GDTC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BIVI GDTC Biotechnology median
Market cap 9.64m 10.30m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack